Shareholders question the motivation for such a significant price tag for Livongo
New York/Paris — Teladoc Health, a US supplier of virtual health care, agreed to buy Livongo Health, which helps manage diabetes with connected devices, for about $18.5bn, as the novel coronavirus pandemic spurs demand for remote medicine.
However, investors appeared to take a cautious view of the proposed terms. Livongo shares were down 8.5% at $132.27 at 9.45am on Wednesday in New York, while Teladoc shares fell 15%. , according to Holz, when the stock has been performing well and when “barriers to entry here do not seem overly significant”.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Investors launch climate plan to get to net zero emissions by 2050Many investors have pledged high-level support to the goals of the 2015 Paris deal.
Read more »
Strict Covid-19 regulations dry up SA wine tourismLockdowns cost the industry more than R2.5bn from March-July
Read more »
Bad debt charges could reach $13bn in 2020, HSBC warnsHSBC’s UK business has been hit particularly hard, as it took a $1.5bn charge against expected credit losses
Read more »
Commerzbank abandons full-year forecast after Wirecard hitThe German lender says it may have to set aside as much as €1.5bn in 2020 for bad loans
Read more »
Alcohol ban shatters Consol Glass R1.5bn new plant investmentThe alcoholic beverages industry accounts for about 85% of sales in the glass packaging industry, which expects to fall by about 15% over the next year
Read more »
Consol halts R1.5bn investmentConsol says there’s been reduced demand for glass products due to the COVID-19 pandemic and the lockdown.
Read more »